Wednesday, February 22, 2006

 

It's good to be a Marshian

Although up until recently it really sucked to be a Marshian. However, today the stock of Marsh Supermarkets soared after the company announced in its earnings release that a recent appraisal of its real estate holdings revealed that their estimated market value exceeds their book value by $100 to $150 million. Not bad for a $70 million company that is already trading below tangible book. Unfortunately, even with today's surge, I'm still underwater on this position, so hopefully the stock will continue to move higher in the days ahead. Largely because of Marsh, my portfolio gained 1.7 percent for the day, taking it to an all time high.

In other news, I will be travelling on business in Asia over the next 2 weeks so I won't be able to post to the blog regularly. However, I'll try to post a few entries here and there, especially if something noteworthy happens in my portfolio.

Comments:
I enjoy your posts and stock picks. You are 10 times better than Cramer.
 
On Marsh, Do you think its possible the run up in price, and the added volume was actually due to the 13 days of naked short selling that needed to be covered? Check out this article I found on Ameritrade:

BUYINS.NET: CAB, GNBT, MARSA, SCU, VQPH, SKFT have been on BUYINS.NET naked short list for 13 consecutive trading days


By M2
Last Update: 2/21/2006 9:34:49 AM Data provided by

Feb 21, 2006 (M2 PRESSWIRE via COMTEX) -- BUYINS.NET, www.buyins.net, announced today that these select companies have been on the NASDAQ, AMEX and NYSE naked short threshold lists for 13 consecutive trading days: Cabela's Incorporated (CAB), Generex Biotechnology Corporation (GNBT), Marsh Supermarkets, Inc. (MARSA), Storm Cat Energy Corporation (SCU), VioQuest Pharmaceuticals, Inc. (VQPH), StrikeForce Technologies, Inc. (SKFT). For a complete list of companies on the naked short lists please visit our web site. To find the SqueezeTrigger Price before a short squeeze starts in any stock, go to www.buyins.net.

Regulation SHO took effect January 3, 2005, and provides a new regulatory framework governing short selling of securities. It was designed with the objective of simplifying and modernizing short sale regulation and providing controls where they are most needed. At the conclusion of each settlement day, data is provided on securities in which: 1) there are at least 10,000 shares in aggregate failed deliveries for the security for five consecutive settlement days, and 2) these failures constitute at least 0.5% of the issuer's total shares outstanding. Regulation SHO mandates that, if a clearing agent has had a fail-to-deliver position for 13 consecutive settlement days, that clearing agent, and the broker/dealer it clears for, must purchase securities to close out its fail to deliver position.

Cabela's Incorporated (CAB) operates as a direct marketer and a multichannel retailer of hunting, fishing, camping, and related outdoor merchandise. Its products include hunting, fishing, marine, and camping merchandise; casual and outdoor apparel, and footwear; optics; vehicle accessories; and gifts and home furnishings. The company markets its products through catalog mailings, the Internet, and retail stores. As of October 14, 2005, the company operated 14 destination retail store in Rogers, Minnesota; 2 destination retail stores in Fort Worth and Buda, Texas; and 1 store in Lehi, Utah. The company was founded in 1961 and is headquartered in Sidney, Nebraska. With 73.06 million shares outstanding and 4.47 million shares declared short as of January 10th, the failure to deliver in shares of CAB has not been resolved and a buy-in is imminent.

Generex Biotechnology Corporation (GNBT) engages in the research and development of drug delivery systems and technology. It develops a proprietary platform technology for the delivery of drugs into the human body through the oral cavity. The company's primary product, Oral-lyn is an insulin spray formulation used for the treatment of Type-1 and Type-2 diabetes. It also develops Gluco-gyn, a formulated glucose spray used for the treatment of hypoglycemia in people with diabetes, as well as morphine and fentanyl by oral formulation and injection for the treatment of moderate to severe breakthrough and postoperative pain. In addition, the company develops technology for the oral administration of molecule drugs, including proteins, peptides, monoclonal antibodies, hormones, and vaccines. It also engages in the research and development of technologies and immunomedicines for the treatment of malignant, infectious, autoimmune, and allergic diseases. Generex Biotechnology was founded in 1983 and is based in Toronto, Canada. With 63.53 million shares outstanding and 1.91 million shares declared short as of January 10th, the failure to deliver in shares of GNBT has not been resolved and a buy-in is imminent.

Marsh Supermarkets, Inc. (MARSA) operates regional grocery chains in the United States. It operates supermarkets under Marsh brand name and convenience stores under the Village Pantry brand name. Marsh supermarkets feature a line of traditional grocery store items, as well as service and specialty departments, such as delicatessens, bakeries, prepared foods, prime cut meats, fresh seafood, floral, and video rental. As of April 2, 2005, the company operated 104 supermarkets in central Indiana and 13 in western Ohio. The Village Pantry convenience stores offer a selection of grocery, bakery, dairy, and delicatessen items. As of the above date, MSI operated 161 convenience stores. In addition, it also owns and operates a food service division under the trade name Crystal Food Services, which provides catering, vending, office coffee, coffee roasting, concession services, and cafeteria management services. Further, MSI operates a floral division, which operates seven upscale retail floral shops under the name McNamara and one business florist under the name Enflora. The company was founded in 1931 and is headquartered in Indianapolis, Indiana. With 7.91 million shares outstanding and 18,510 shares declared short as of January 10th, the failure to deliver in shares of MARSA has not been resolved and a buy-in is imminent.

Storm Cat Energy Corporation (SCU) an exploration stage company, engages in the acquisition, exploration, and development of unconventional natural gas, including coalbed methane gas, as well as oil properties in Mongolia, Canada, and the United States. Its properties primarily include Noyon West and Tsaidam projects, 2 coalbed methane exploration projects, consisting of approximately 49,101 square kilometers located in the South Gobi area, Mongolia; and North East Spotted Horse Field, comprising 71 producing wells covering approximately 6,320 gross contiguous acres located in the Powder River Basin of Wyoming. The company also owns 100% working interest in 3 petroleum and natural gas exploration leases covering approximately 22,116 acres located in the Cook Inlet region of Alaska. As of September 30, 2005, it had total proved net reserves on the Powder River Basin of approximately 9.932 billion cubic feet. The company was formed in 2000. It was formerly known as Toby Ventures, Inc. and changed its name to Storm Cat Energy Corporation in 2004. Storm Cat is based in Vancouver, Canada. With 51.20 million shares outstanding and an undisclosed short position, the failure to deliver in shares of SCU has not been resolved and a buy-in is possible.

VioQuest Pharmaceuticals, Inc. (VQPH) engages in the acquisition, development, and commercialization of targeted late preclinical and early clinical stage therapies for oncology, viral, and autoimmune disorders. The company is developing two novel anti-cancer agents, VQD-001, a PTPase inhibitor for the treatment of melanoma, myeloma, and lymphoma; and VQD-002, a direct Akt inhibitor for the treatment of breast, ovarian, pancreatic, and colorectal cancers. VioQuest's life science subsidiary, Chiral Quest, Inc., offers contract process development services, proprietary chiral catalysts, ligands, and building blocks and synthesis for creating important chiral intermediates and products. Through Chiral Quest, the company provides products and services in all stages of product life cycles to various chemical manufacturers and pharmaceutical companies worldwide. VioQuest is based in Monmouth Junction, New Jersey. With 46.73 million shares outstanding and an undisclosed short position, the failure to deliver in shares of VQPH has not been resolved and a buy-in is possible.

StrikeForce Technologies, Inc. (SKFT) operates as a software development and services company. It provides identity assurance solutions to both industry and government sectors. The company's principal product is ProtectID, an authentication platform that uses out-of-band procedures to authenticate computer network users by a variety of methods, including traditional passwords combined with a telephone or multiple computer secure sessions; biometric identification; or encrypted devices, such as tokens or smartcards. Its other products include VerifyID, a software application that verifies the identity of an end user or applicant by asking a series of questions based on publicly available information; TrustedID, a software application intended to provide security by validating the authenticity of computer trying to log-in to an enterprise network or Web service using a device ID' that is machine-specific; GuardedID, which creates a 128 bit encrypted separate pathway for information delivery from a keyboard to a targeted application at a local computer; and ResetID, which provides user authenticated out-of-band remote technology to reset user credentials through a self-service method. In addition, the company distributes and resells related technology software and hardware products. These products include cameras, and additional authentication and telecommunication software and hardware devices. The company was organized in 2001. It was formerly known as StrikeForce Technical Services Corporation and changed its name to StrikeForce Technologies, Inc. in September 2004. StrikeForce Technologies is headquartered in Edison, New Jersey. With 18.03 million shares outstanding and an undisclosed short position, the failure to deliver in shares of SKFT has not been resolved and a buy-in is possible.

About BUYINS.NET

WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.

BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted, www.buyins.net/squeezetrigger.pdf. The SqueezeTrigger database of nearly 600,000,000 short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each month's short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money.

All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET may receive compensation in cash or shares from independent third parties or from the companies mentioned.

BUYINS.NET affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. Market commentary provided by Thomas Ronk.

BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.

You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.

CONTACT: Thomas Ronk, CEO Tel: +1 800 715 9999 e-mail: Tom@buyins.net WWW: http://www.buyins.net

M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
 
Post a Comment

<< Home

This page is powered by Blogger. Isn't yours?